A major trial to determine whether intensive lifestyle intervention would reduce cardiovascular (CV) morbidity and mortality in type 2 diabetes patients has been stopped early because of failure to show benefit in the intervention group. Nevertheless, clinicians may confidently advise patients that improvements in diet and activity will reduce weight, the need for medications and the incidence of sleep apnoea and will improve wellbeing.